KEAP1/NFE2L2 Mutations Predict Lung Cancer Radiation Resistance That Can Be Targeted by Glutaminase Inhibition
KEAP1/NFE2L2 突变可预测肺癌放射抗性,而谷氨酰胺酶抑制剂可作为靶点。
期刊:Cancer Discovery
影响因子:29.7
doi:10.1158/2159-8290.CD-20-0282
Michael S Binkley # ,Young-Jun Jeon # ,Monica Nesselbush ,Everett J Moding ,Barzin Y Nabet ,Diego Almanza ,Christian Kunder ,Henning Stehr ,Christopher H Yoo ,Siyeon Rhee ,Michael Xiang ,Jacob J Chabon ,Emily Hamilton ,David M Kurtz ,Linda Gojenola ,Susie Grant Owen ,Ryan B Ko ,June Ho Shin ,Peter G Maxim ,Natalie S Lui ,Leah M Backhus ,Mark F Berry ,Joseph B Shrager ,Kavitha J Ramchandran ,Sukhmani K Padda ,Millie Das ,Joel W Neal ,Heather A Wakelee ,Ash A Alizadeh ,Billy W Loo Jr ,Maximilian Diehn